Clinical Trial Update: Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update outlines an early-phase (Phase 1/2) study evaluating the combination of aclarubicin with azacitidine and venetoclax for acute myeloid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Aclarubicin (aclarubicin)
• Venetoclax (venetoclax)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Acute Myeloid Leukemia (AML), Relapse Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING